The association of arterial stiffness index with cerebrovascular and cardiometabolic disease: A Mendelian

Weishi Liu1,2,3, Luyang Zhang1,2, Yuan Gao1,2

  • 1Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Insights

Arterial stiffness index (ASI) may increase the risk of ischemic stroke (IS). This Mendelian randomization study found a link between genetically predicted ASI and higher IS risk, particularly large artery atherosclerosis stroke.

Area of Science:

  • Cardiovascular epidemiology
  • Genetics
  • Neurology

Background:

  • Arterial stiffness index (ASI) is a potential risk factor for cerebrovascular and cardiometabolic diseases.
  • Causal links between ASI and these diseases remain inconclusive.

Purpose of the Study:

  • To evaluate the causal effects of ASI on cerebrovascular and cardiometabolic diseases using Mendelian randomization (MR).

Main Methods:

  • Two-sample MR analysis utilizing genetic variants associated with ASI.
  • Inverse variance weighted method for effect estimation.
  • Sensitivity analyses to assess heterogeneity and pleiotropy.

Main Results:

  • Genetically predicted ASI showed a significant association with an increased risk of all-cause ischemic stroke (IS) (OR = 1.894, p = 0.005).
  • A suggestive association was observed between genetically predicted ASI and large artery atherosclerosis stroke (LAS) (OR = 3.726, p = 0.020).
  • No significant links were found between ASI and other cerebrovascular or cardiometabolic diseases, or specific IS etiologies like cardioembolism or small vessel occlusion.

Conclusions:

  • Genetically predicted ASI is associated with an elevated risk of ischemic stroke.
  • Further research is needed to elucidate the underlying pathways and mechanisms connecting ASI and IS.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
27
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
35
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31